AI assistant
Sending…
Co-Diagnostics, Inc. — Director's Dealing 2017
Sep 8, 2017
35011_dirs_2017-09-08_75f00a3f-93ae-4d53-9fd7-aa1d05ea4901.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Co-Diagnostics, Inc. (CODX)
CIK: 0001692415
Period of Report: 2017-07-11-06:00
Reporting Person: Legends Capital Group, LLC (N/A)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1300344 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Warrant | $6.00 | 2020-11-12-07:00 | Common Stock (4545) | Direct |
More from Co-Diagnostics, Inc.
Capital/Financing Update
2026
May 28
Capital/Financing Update
2026
May 21
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Major Shareholding Notification
2026
Feb 11
Regulatory Filings
2026
Jan 21
Delisting Announcement
2026
Jan 13
Share Issue/Capital Change
2025
Dec 30
Capital/Financing Update
2025
Dec 19
Declaration of Voting Results & Voting Rights Announcements
2025
Dec 5